Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Editorial: Novel modalities in cancer diagnostics and therapeutics

Frontiers in Pharmacology(2022)10.3389/fphar.2022.1101506Source: DataRank Database

Editorial: Novel modalities in cancer diagnostics and therapeutics is a research paper published in Frontiers in Pharmacology (2022). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)OA: goldTopics (23)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Dong‐Hua Yang ORCID,Haichang Li ORCID,Li Zhao ORCID

Live enrichment

PubMed:36532765 OpenAlex:https://openalex.org/W4311040526

National Institutes of Health

Grant: 1R21AR080628-01

Development of a protein therapeutics to counteract mustard-induced skin injury

National Institutes of Health

Grant: 5R01AG056919-05

Hydrogel encapsulation of a tissue repair protein to treat chronic wounds

goldLicense: cc-by

journalhttps://www.frontiersin.org/articles/10.3389/fphar.2022.1101506/pdf

publisherhttps://www.frontiersin.org/articles/10.3389/fphar.2022.1101506/pdf

publisherhttps://www.frontiersin.org/articles/10.3389/fphar.2022.1101506/full

journalhttps://doi.org/10.3389/fphar.2022.1101506

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36532765

Fields of Study

Protein Degradation and InhibitorsPARP inhibition in cancer therapyEpigenetics and DNA Methylation0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

MedicineCancer drugsDrug discoveryModalitiesPharmacologyDrugComputational biologyBioinformaticsBiologydiagnosticstherapeuticscancerPharmacology (medical)Therapeutics. PharmacologyRM1-950novel modalitiestechnologies

Sustainable Development Goals

SDG 0: Good health and well-being